This Element analyses the tension between innovation and financialisation in the UK pharmaceutical industry, focusing on AstraZeneca and GlaxoSmithKline. This title is also available as Open Access on Cambridge Core.
The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a)... Læs mere
The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a)... Læs mere